Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06808776 · ClinicalTrials.gov registry record · NA
Stories to Prevent (StoP) HPV Cancers
A NA study of Emotions and Human Papillomavirus Vaccination, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06808776: Recruiting NA study of Emotions and Human Papillomavirus Vaccination, sponsored by Milton S. Hershey Medical Center.
NCT06808776 is a NA study of Emotions and Human Papillomavirus Vaccination that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 200 participants, above the 175-participant average among 16 other Emotions trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06808776, a NA study of Emotions and Human Papillomavirus Vaccination, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates among 9- to 12-year-olds. The intervention is a brief video from local cancer survivors narrating their stories with an HPV-related cancer diagnosis and recommending the HPV vaccine for cancer prevention. RCT participants will be the parents (n=200) of children ages 9-12 who have not initiated HPV vaccination. Participants will be randomized (1:1) to our intervention or control (placebo video) one week before their child's next primary care visit. Our primary outcome is HPV vaccine initiation (first dose of the HPV vaccine series) among children ages 9-12 at the time of the wellness visit. The study also explores the effect of narratives on theory-based mediators of HPV vaccination, including parents' cognitive (e.g., risk perception) and emotional reactions (e.g., hope, anticipated regret).
Primary Outcome
The proportion of children ages 9-12 who have initiated HPV vaccination (first dose) during their scheduled clinic visit.
Conditions Studied
Interventions
- OTHER Cancer survivor narrative
- OTHER Healthy eating tips
Study Locations (1)
Pennsylvania
- Penn State Health - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-11-18 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT06808776 shows while recruiting
NCT06808776 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 175-participant average among 16 other Emotions trials with a reported enrollment target (14% higher).
The record links to 2 conditions, with Emotions appearing as the primary indexed condition, and to 2 interventions - of which Cancer survivor narrative is the first listed.
NCT06808776 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06808776 about?
NCT06808776 is a clinical study titled "Stories to Prevent (StoP) HPV Cancers". This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates among 9- to 12-year-olds. The intervention is a brief video from local cancer survivors narrating their stories with an HPV-related cancer diagno...
What is the current status of trial NCT06808776?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-11-18. Estimated completion is 2027-03-31.
What conditions does trial NCT06808776 study?
This clinical trial studies the following conditions: Emotions, Human Papillomavirus Vaccination.
What interventions are being tested in trial NCT06808776?
The interventions under investigation include: Cancer survivor narrative (OTHER), Healthy eating tips (OTHER).
Who is sponsoring clinical trial NCT06808776?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06808776 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06808776's enrollment target sits among peer trials
200 5th of 16 higher than 11 of 16 other Emotions trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emotions trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
State-dependent Interoception, Value-based Decision-making, and Introspection
RECRUITING · NA
-
Geolocation Positional System (GPS) Experience
RECRUITING · NA
-
Alcohol & Men's Sexual Risk Behaviors
RECRUITING · NA
-
Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults
ACTIVE NOT RECRUITING · NA
-
Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI